Free Trial
NASDAQ:SCPH

scPharmaceuticals (SCPH) Stock Price, News & Analysis

scPharmaceuticals logo
$4.08 +0.12 (+3.03%)
Closing price 04:00 PM Eastern
Extended Trading
$4.07 -0.01 (-0.37%)
As of 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About scPharmaceuticals Stock (NASDAQ:SCPH)

Key Stats

Today's Range
$3.99
$4.18
50-Day Range
$2.24
$4.27
52-Week Range
$1.94
$5.65
Volume
264,990 shs
Average Volume
374,471 shs
Market Capitalization
$215.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Buy

Company Overview

scPharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
83rd Percentile Overall Score

SCPH MarketRank™: 

scPharmaceuticals scored higher than 83% of companies evaluated by MarketBeat, and ranked 172nd out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    scPharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    scPharmaceuticals has received no research coverage in the past 90 days.

  • Read more about scPharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for scPharmaceuticals are expected to grow in the coming year, from ($1.53) to ($1.08) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of scPharmaceuticals is -2.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of scPharmaceuticals is -2.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    scPharmaceuticals has a P/B Ratio of 15.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about scPharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    3.64% of the float of scPharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    scPharmaceuticals has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in scPharmaceuticals has recently decreased by 12.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    scPharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    scPharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.64% of the float of scPharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    scPharmaceuticals has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in scPharmaceuticals has recently decreased by 12.02%, indicating that investor sentiment is improving significantly.
  • Search Interest

    2 people have searched for SCPH on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added scPharmaceuticals to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, scPharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.78% of the stock of scPharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    89.52% of the stock of scPharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about scPharmaceuticals' insider trading history.
Receive SCPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for scPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SCPH Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Q1 2025 scPharmaceuticals Inc Earnings Call
See More Headlines

SCPH Stock Analysis - Frequently Asked Questions

scPharmaceuticals' stock was trading at $3.54 at the beginning of the year. Since then, SCPH shares have increased by 15.3% and is now trading at $4.08.

scPharmaceuticals, Inc. (NASDAQ:SCPH) released its earnings results on Wednesday, May, 14th. The company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.28) by $0.06. The company earned $11.75 million during the quarter, compared to the consensus estimate of $11.63 million. scPharmaceuticals had a negative trailing twelve-month return on equity of 594.07% and a negative net margin of 216.24%.
Read the conference call transcript
.

scPharmaceuticals (SCPH) raised $96 million in an initial public offering on Friday, November 17th 2017. The company issued 6,400,000 shares at a price of $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO.

Shares of SCPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that scPharmaceuticals investors own include Voyager Therapeutics (VYGR), Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
5/14/2025
Today
7/09/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SCPH
CIK
1604950
Fax
N/A
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$18.00
Low Price Target
$12.00
Potential Upside/Downside
+243.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$85.15 million
Net Margins
-216.24%
Pretax Margin
-216.24%

Debt

Sales & Book Value

Annual Sales
$36.33 million
Price / Cash Flow
N/A
Book Value
$0.27 per share
Price / Book
15.11

Miscellaneous

Free Float
50,269,000
Market Cap
$215.38 million
Optionable
Optionable
Beta
0.38
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:SCPH) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners